Silence Therapeutics (SLN) Other Working Capital Changes (2024 - 2026)
Silence Therapeutics (SLN) reported Other Working Capital Changes of -$404000.0 for Q1 2026, down 461.11% on a YoY basis from $111876.9 in Q1 2025, and down 114.89% sequentially from -$188000.0 in Q4 2025.
Silence Therapeutics (SLN) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Other Working Capital Changes data on file, last reported at -$404000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 461.11% year-over-year to -$404000.0; the trailing twelve-month figure through Mar 2026 stood at -$666000.0 (down 163.24% YoY), and the FY2025 full-year result was -$334000.0, down 102.42% from the prior year.
- Other Working Capital Changes declined to -$404000.0 in Q1 2026, from -$188000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.9 million in Q2 2024 to a low of -$5.3 million in Q3 2025.
- A 3-year average of -$624111.1 and a median of -$392000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 98.64% in 2025, while the deepest fall reached 683.33% in 2025.
- Tracing SLN's Other Working Capital Changes over 3 years: stood at -$24000.0 in 2024, then sank by 683.33% to -$188000.0 in 2025, then sank by 114.89% to -$404000.0 in 2026.
- Business Quant data shows SLN's Other Working Capital Changes at -$404000.0 in Q1 2026, -$188000.0 in Q4 2025, and -$20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -931,000.00 |
| Mar 31, 2026 | -931,000.00 |
| Mar 31, 2026 | -931,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Sep 30, 2025 | -5.33 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Dec 31, 2024 | -392,000.00 |
| Dec 31, 2024 | -392,000.00 |
| Dec 31, 2024 | -392,000.00 |
| Sep 30, 2024 | -917,000.00 |
| Sep 30, 2024 | -917,000.00 |